Results 231 to 240 of about 4,583,036 (340)
Neutrophil-to-lymphocyte ratio predicts a poor prognosis for penile cancer with an immunosuppressive tumor microenvironment. [PDF]
Tan X +18 more
europepmc +1 more source
Abstract Background Metformin and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) may reduce the risk of adiposity‐related cancers in patients with type 2 diabetes (T2D). The potential synergistic effects of these treatments on cancer incidence remain unclear, considering their distinct biological mechanisms and their associated effects on body ...
Alex E. Henney +6 more
wiley +1 more source
Intraoperative frozen section examination for penile cancer surgery: a systematic review. [PDF]
Yunis MZ +3 more
europepmc +1 more source
Abstract This study investigated how chronic metformin administration modulates the cellular profile and inflammatory markers in a zoledronic acid‐based rat model of medication‐related osteonecrosis of the jaw (MRONJ). Male Wistar rats were allocated to different treatments: (i) naïve, (ii) MRONJ (zoledronic acid, 0.2 mg/kg, i.v.
Liviane Maria Alves Rabelo +10 more
wiley +1 more source
Impact of sarcopenia and fat distribution on outcomes in penile cancer. [PDF]
Hartmann V +10 more
europepmc +1 more source
Summary Background Pituitary pars intermedia dysfunction (PPID) is commonly treated with pergolide mesylate, a dopamine receptor agonist. Cabergoline is a dopamine receptor agonist that has shown activity on prolactin secretion in horses for up to 10 days.
H. Hess +5 more
wiley +1 more source
Penile cancer – Incidence, mortality, and survival in Saxony, Germany
Olaf Schoffer +10 more
openalex +2 more sources
A BioID screen identified interacting proteins for secretory pathway calcium (Ca2+) ATPase 2C (SPCA2C) and showed new links to store‐operated Ca2+ entry. Interactions between SPCA2C and Orai1 were confirmed, along with newly identified interactions with STIM1 and CCDC47.
Petra Samardzija +9 more
wiley +1 more source
Local Therapy and Reconstruction in Penile Cancer: A Review. [PDF]
Zekan D +3 more
europepmc +1 more source

